Products
In this classification an activated whole blood clotting time tests is a device, used to monitor heparin therapy for the treatment of venous thrombosis or pulmonary embolism by measuring the coagulation time of whole blood US FDA regulates Activated whole blood clotting time tests under 21 CFR 864.7140 and under FDA product code JBP.
How AGI delivers it
Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
For Activated whole blood clotting time tests, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
Get the professional outcome delivered as software, priced on results, not headcount.
For Activated whole blood clotting time tests, get the professional outcome delivered as software, priced on results, not headcount.
Value flow
Go deeper